红树林免疫增强真菌的筛选及菌株PH0016的鉴定探讨

目的:探讨红树林免疫增强真菌的筛选及菌株PH0016鉴定。方法:对采集获得的红树林土壤样本进行分离和培养,选取单独的菌落群,使用分区划线法进行纯化。将选取的单独菌落群接种在海水马丁氏的培养基平板上,对接种的培养基进行环绕式烧灼以达到灭菌目的。对纯化后的菌株进行编号,置于实验菌种库中进行保存,恒温4℃。取单独的菌落,置于发酵培养基中,以每分钟250转的速度进行离心,置于恒温28℃的摇床中进行连续5天的培养。采取四甲基偶氮唑盐方法对PH0016菌株的免疫活性进行检测。观察菌株的菌落情况、形态以及r DNA ITS序列,对菌株PH0016进行鉴定。结果:本次分离出325株真菌,其中12株真菌具有免疫增强作用。通过r DNA ITS序列分析联合同源性检索,PH0016与拟青霉属的相似性达到100%。结论:菌株PH0016具有较强的免疫增强活性,能够促进外周血单个核细胞的增殖。菌株PH0016为拟青霉属丛梗孢科菌株,能够有效增强免疫功能。     

海南文昌清澜港红树林真菌抗B16肿瘤细胞活性菌株的筛选

从海南文昌清澜港红树林采集78份植物组织和土壤样品。对样品进行真菌分离, 共分离得到真菌608株, 采用目测法对其体外抗肿瘤细胞活性进行检测, 发现81株红树林真菌对小鼠黑色素瘤B16细胞有不同程度的抑制作用, 占总分离菌株的13.32%。结果表明, 从红树植物杯萼海桑中分离得到真菌菌株的数量最多, 而从红树植物银叶树分离得到的抗肿瘤细胞活性菌株数量最多。     

褐藻裙带菜孢子叶粗提物体外抗单纯疱疹病毒Ⅱ型活性研究

从药物对细胞的保护、对HSV-2增殖的影响及对HSV-2感染细胞的综合作用三个方面研究不同稀释度的裙带菜孢子叶粗提物抑制单纯疱疹病毒Ⅱ型对Vero细胞的感染作用,细胞病变效应法(Cytopathogenic effect,CPE)观察和MTT法测定裙带菜多糖抗HSV-2活性,结果表明裙带菜多糖能明显抑制HSV-2对Vero细胞的致病变作用,使细胞存活率升高,其水提醇沉法所得裙带菜多糖的IC50为6.49μg/mL,并初步推测其抗HSV-2活性是作用在HSV-2和受体结合,侵入Vero细胞阶段,为筛选新型抗病毒药物、研究海藻多糖抗HSV-2活性机理及优化裙带菜孢子叶的提取工艺提供参考依据。     

海南文昌清澜港红树林真菌抗B16肿瘤细胞活性菌株的筛选

从海南文昌清澜港红树林采集78份植物组织和土壤样品。对样品进行真菌分离, 共分离得到真菌608株, 采用目测法对其体外抗肿瘤细胞活性进行检测, 发现81株红树林真菌对小鼠黑色素瘤B16细胞有不同程度的抑制作用, 占总分离菌株的13.32%。结果表明, 从红树植物杯萼海桑中分离得到真菌菌株的数量最多, 而从红树植物银叶树分离得到的抗肿瘤细胞活性菌株数量最多。     

小花清风藤水提物体内抗流感病毒的研究

目的:研究小花清风藤水提物体内抗流感病毒的活性。方法:采用滴鼻感染流感病毒建立BALB/c小鼠肺炎模型,以小鼠存活率、平均存活时间、肺指数、肺组织中病毒滴度及肺组织病理改变为指标,观察不同剂量小花清风藤水提物体内抗流感病毒的活性。结果:与模型组比较,小花清风藤水提物中剂量(i.g,6.5 g/kg)能提高小鼠生存率30%,延长小鼠存活时间,降低小鼠肺指数和肺组织中病毒滴度,明显改善感染小鼠肺组织炎症病变。结论:小花清风藤水提物在体内具有一定的抗流感病毒的作用。     

漳江口红树林沉积物真菌多样性分析及抗茶叶致病真菌生物活性筛选

以福建漳江口红树林国家级自然保护区红树林沉积物分离的真菌为对象,研究红树林沉积物真菌的多样性和筛选抗茶叶病原真菌活性的菌株。将分离纯化的135株真菌通过形态学和Ribosomal DNA-Internal Transcribed Spacer(rDNAITS)序列测定进行鉴定及多样性分析,归为40个种类型,分别属于17个属,其中青霉属(25%)为优势菌,木霉属(15%)、曲霉属(10%)和镰刀属(10%)次之,表明红树林沉积物真菌具有丰富的多样性;利用平板对峙法对真菌的发酵粗提物抗茶叶病原真菌生物活性研究,结果发现,共有17株(占42.5%)真菌具有抗茶叶病原真菌活性,其中15株能够抑制茶叶轮斑病(Pestalotiopsis theae)LH13,12株能够抑制茶叶炭疽病(Colletotrichum gloeosporioides)LH30,8株能够抑制茶叶溃疡病(Neofusicoccumsp.)LH107,有两株对这三种茶叶致病菌均有较强活性。这些活性菌株分布在6个属中,分别是青霉属(7株)、木霉属(3株)、镰孢属(2株)、枝孢属(2株)、白地霉属(2株)和球腔菌属(1株)。由此可见,红树林沉积物真菌抗菌活性菌株的种属分布具有多样性。     

当归注射液有效成分的抗低氧保护作用

目的：研究梯度分离的当归注射液有效成分（5-HMF）对小鼠及体外培养的ECV304细胞的抗低氧保护作用。方法：观察常压低氧和低压低氧下小鼠存活时间 通过MTT比色法检测ECV304细胞经低氧后的细胞存活率、并以台盼蓝染色检测细胞死亡率来评价药效。结果：与低氧组比较,加药低氧后,小鼠存活时间延长（P〈0.05） 低氧后细胞存活率降低,死亡率升高,而加入当归注射液有效成分（5-HMF）处理的细胞存活率明显高于低氧对照组（P〈0.01）,死亡率亦明显降低（P〈0.01）。结论：当归注射液有效成分（5-HMF）对小鼠及体外培养的ECV304细胞均具有抗低氧保护作用。     

具有抗菌和细胞毒活性红树林真菌的鉴定分析

此次研究从海南省文昌红树林分离到的29株具有抗白色念珠菌和/或细胞毒活性真菌,分别采用核算序列分析、生理生化特征、形态观察对其进行鉴定。研究结果显示,29株真菌中,曲霉属(Aspergillus)7株,青霉属(Penicillium)16株,正青霉属(Eupenicillium)1株、新萨托菌属(Neosartorya)1株、拟青霉属(Paecilomyces Bainier)1株,暂不能定属3株。     

杜仲内生真菌DZ05的鉴定及抗菌生物活性研究

结合菌株的形态学特征和ITS序列分析结果,对1株分离自杜仲茎部的内生真菌菌株DZ05进行鉴定,并对其在PDA液体培养基摇床培养3 d获得的发酵液对多种测试菌进行抗菌活性研究。结果显示:(1)分离自杜仲茎部的内生真菌菌株DZ05经形态学特征和ITS序列分析,被鉴定为淡紫色拟青霉。(2)其发酵液的乙酸乙酯提取物对6种测试细菌和9种测试植物病原菌均具有明显的抑菌活性,抑菌圈直径在13～45 mm之间,其中对番茄灰霉病菌、番茄叶霉病菌和苹果炭疽病菌抑菌圈直径＞40 mm。研究表明,杜仲内生真菌DZ05的代谢产物具有广谱的抗菌活性,在植物病原菌的生物防治领域具有较大的应用前景。     

Ⅰ型单纯疱疹病毒感染的细胞培养系统的建立

目的:建立稳定的HSV-1感染的细胞培养系统,为HSV-1感染性皮肤病的基础及临床研究提供稳定的平台。方法:以猴肾细胞(Vero)为繁殖细胞,选择人鼻咽癌上皮细胞(Hep-2)为靶细胞,观察HSV-1在Hep-2株中的致细胞病变效应(CPE)。结果:HSV-1在Vero细胞中能稳定、大量地繁殖;HSV-1感染Hep-2细胞后可出现明显的细胞病变;结论:以Vero为繁殖细胞,Hep-2为靶细胞的稳定的细胞培养系统可作为HSV-1感染性皮肤病的基础及临床研究的平台。     

Antiviral activity of recombinant cyanovirin-N against HSV-1

In this study, a standard strain of HSV-1 (strain SM₄₄) was used to investigate the antiviral activity of the recombinant Cyanovirin-N (CV-N) against Herpes simplex virus type 1 (HSV-1) in vitro and in vivo. Cytopathic effect (CPE) and MTT assays were used to evaluate the effect of CV-N on HSV-1 in Vero cells. The number of copies of HSV-DNA was detected by real-time fluorescence quantitative PCR (FQ-PCR). The results showed that CV-N had a low cytotoxicity on Vero cells with a CC₅₀ of 359.03±0.56 μg/mL, and that it could not directly inactivate HSV-1 infectivity. CV-N not only reduced the CPE of HSV-1 when added before or after viral infection, with a 50% inhibitory concentration (IC₅₀) with 2.26 and 30.16μg/mL respectively, but it also decreased the copies of HSV-1 DNA in infected host cells. The encephalitis model for HSV-1 infection was conducted in Kunming mice, and treated with three dosages of CV-N (0.5, 5 &; 10 mg/kg) which was administered intraperitoneally at 2h, 3d, 5d, 7d post infection. The duration for the appearance of symptoms of encephalitis and the survival days were recorded and brain tissue samples were obtained for pathological examination (HE staining). Compared with the untreated control group, in the 5mg/kg CV-N and 10mg/kg CV-N treated groups, the mice suffered light symptoms and the number of survival days were more than 9d and 14d respectively. HE staining also showed that in 5mg/kg CV-N and 10mg/kg CV-N treated groups, the brain cells did not show visible changes, except for a slight inflammation. Our results demonstrated that CV-N has pronounced antiviral activity against HSV-1 both in vitro and in vivo, and it would be a promising new candidate for anti-HSV therapeutics.     

Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta

To evaluate the anti-HSV-1 mechanisms of murine IFN-beta in ocular infection, mice were transduced with an adenoviral vector expressing murine IFN-beta (Ad:IFN-beta). Ocular transduction with Ad:IFN-beta resulted in enhanced survival following infection with HSV-1. The protective effect was associated with a reduction in 1) viral titer, 2) viral gene expression, 3) IFN-gamma levels, and 4) the percentage of CD8(+) T lymphocyte and NK cell infiltration in infected tissue. Expression of IFN-beta resulted in an elevation of the IFN-induced antiviral gene 2',5'-oligoadenylate synthetase (OAS1a) but not dsRNA-dependent protein kinase R (PKR) in the cornea and trigeminal ganglion (TG). Mice deficient in the downstream effector molecule of the OAS pathway, RNase L, were no more sensitive to ocular HSV-1 compared with wild-type controls in the TG based on measurements of viral titer. However, the efficacy of Ad:IFN-beta was transiently lost in the eyes of RNase L mice. By comparison, PKR-deficient mice were more susceptible to ocular HSV-1 infection, and the antiviral efficacy following transduction with Ad:IFN-beta was significantly diminished in the eye and TG. These results suggest that PKR is central in controlling ocular HSV-1 infection in the absence of exogenous IFN, whereas the OAS pathway appears to respond to exogenous IFN, contributing to the establishment of an antiviral environment in a tissue-restricted manner.     

Efficacy of therapeutic and prophylactic actions of ultralow doses of antibodies to gamma-interferon in experimental murine model of herpes virus]

The process of the disease due to herpes simplex virus types 1 and 2 (HSV-1 and 2) was studied on white uninbred mice weighing 10 to 12 g. The animals were infected intracerebrally or intraperitoneally. Intraperitoneal contamination of the animals with MS strain of HSV-2 was used for the experimental model of the herpes simplex infection. The prophylactic antiherpes action of ultralow doses of the human gamma-interferon antibodies (ULD of anti-IFN-gamma) at a course of its intragastral administration was evaluated. The preparation was shown to have a significant (p < 0.05) protective effect in a dose of 10 LD50, evident from a 10-fold decrease of the HSV-2 accumulation in the brain, a lower percentage of the animal deaths and an increase of the average lifespan of the animals by 3.3 days. The study of the therapeutic action of ULD of anti-IFN-gamma at a course of its intragastral administration showed that the preparation had no significant positive effect on the disease process in the animals infected with HSV-2 in a dose of 10 LD50. However, a positive effect associated with delayed virus replication in the brain was observed in the study on the therapeutic effect of ULD of anti-IFN-gamma after its intragastral administration to the mice infected with a sublethal dose of the virus.     

In vitro inhibition of the cytopathic action of herpes simplex virus, type 1, with a natural cytokine complex

The antiviral action of a natural cytokine complex (NCC)--the preparation Superlymph and its peptide antimicrobial fraction (AMF)--in the culture of Vero cells infected with type 1 herpes simplex virus (HSV-1), strain VR-3, was studied. The NCC preparation did not alter the morphology of the cells for 6 days and was not toxic for the culture of Vero cells. The NCC and AMF produced a protective antiviral effect, which was manifested by the inhibition of the cytopathic action (CPA) of the virus. In the presence of the preparation, the CPA of HSV-1 was equal to 10(-4.67) ICPD50, while in the control CPA was equal to 10(-5.60). The fraction containing antimicrobial peptides (protegrins) and isolated from NCC, characterized by the method of mass spectrometry, produced the maximum antiviral effect on the cell strain Vero (10(-4.58) ICPD50). Thus Superlymph, an immunomodulator with antiviral activity, could be regarded as an effective preparation for the treatment of HSV infection. The action of such preparation was aimed at the inhibition of the CPA of the virus and the stimulation of the antiviral protective mechanisms of the cell.     

Anti-herpesvirus activities of Pseudomonas sp. S-17 rhamnolipid and its complex with alginate

The rhamnolipid biosurfactant PS-17 and its complex with the polysaccharide alginate, both produced by the Pseudomonas sp. S-17 strain, were studied for their antiviral activity against herpes simplex virus (HSV) types 1 and 2. They significantly inhibited the herpesvirus cytopathic effect (CPE) in the Madin-Darby bovine kidney (MDBK) cell line. The investigations were carried out according to the CPE inhibition assay protocol. The suppressive effect of the compounds on HSV replication was dose-dependent and occurred at concentrations lower than the critical micelle concentration of the surfactant. The 50% inhibitory concentration (IC50) of rhamnolipid PS-17 was 14.5 microg/ml against HSV-1 and 13 microg/ml against HSV-2. The IC50 values of the complex were 435 microg/ml for HSV-1 and 482 microg/ml for HSV-2. The inhibitory effects of the substances were confirmed by measuring the infectious virus yields with the multicycle virus growth experimental design as well: deltalog CCID50 of 1.84-2.0 against the two types of herpes simplex viruses by rhamnolipid PS-17 (20 microg/ml), and a strong reduction of the HSV-2 virus yield under the effect of the alginate complex at a concentration of 450 microg/ml. The results indicate that rhamnolipid PS-17 and its alginate complex may be considered as promising substances for the development of anti-herpetic compounds.     

Antiviral property and mechanisms of a sulphated polysaccharide from the brown alga Sargassum patens against Herpes simplex virus type 1

A sulphated polysaccharide (SP-2a) from the brown alga Sargassum patens (Kütz.) Agardh (Sargassaceae) was found to significantly inhibit the in vitro replication of both the acyclovir (ACV)-sensitive and -resistant strains of Herpes simplex virus type 1 (HSV-1), in dose-dependent manners, with 50% inhibitions occurring with 1.5–5.3 μg/ml of the polysaccharide. SP-2a exhibited extracellular virucidal activity only against the ACV-sensitive strains, but not the resistant strain, at the concentration of 100 μg/ml. The strongest antiviral activities against the different strains of HSV-1 were observed when this polysaccharide was present during and after adsorption of the virus to host cells. The inhibitory effect of SP-2a on virus adsorption occurred dose-dependently in all the HSV-1 strains tested, and the adsorption of the ACV-resistant DM2.1 strain was reduced by 81.9% (relative to control) with 4 μg/ml of the polysaccharide. This study clearly demonstrated that the antiviral mode of action of SP-2a is mediated mainly by inhibiting virus attachment to host cells, and this sulphated polysaccharide might have different modes of action against the ACV-sensitive and -resistant strains of HSV-1.     

Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon.

BALB/c mice infected on the scarified cornea with herpes simplex virus type 1 strain 35 [HSV-1(35)] rarely developed ocular disease even at challenge doses as high as 10(7) PFU per eye. In contrast, HSV-1(RE) consistently induced stromal keratitis at an inoculum of 2 x 10(4) PFU. The goal of this study was to determine the reason for the difference in virulence between the two HSV strains. Both HSV-1 strains replicated to similar titers in excised corneal "buttons." However, after in vivo infection of the cornea, the growth of strain 35 was evident only during the first 24 h postinfection, whereas the replication of strain RE persisted for at least 4 days. In vitro tests revealed that HSV-1(35) was greater than 10 times more sensitive to alpha/beta interferon (IFN-alpha/beta) than HSV-1(RE). Both strains induced comparable serum levels of IFN after intraperitoneal inoculation. The kinetics of HSV-1(35) clearance from the eye was markedly altered by treatment with rabbit anti-IFN-alpha/beta. Virus titers exceeding 10(4) PFU per eye could be demonstrated 4 to 5 days postinfection in mice given a single inoculation of antiserum 1 h after infection. Furthermore, anti-IFN treatment in 3-week-old mice infected with HSV-1(35) led to the development of clinically apparent corneal disease which subsequently progressed to stromal keratitis in the majority of recipients. These results indicate that the striking difference in the capacity of HSV-1(35) and HSV-1(RE) to induce corneal disease was related to the inherently greater sensitivity of strain 35 to IFN-alpha/beta produced by the host in response to infection.     

Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production

Toll-like receptors (TLRs) constitute a family of innate receptors that recognize and respond to a wide spectrum of microorganisms, including fungi, bacteria, viruses, and protozoa. Previous studies have demonstrated that ligands for TLR3 and TLR9 induce potent innate antiviral responses against herpes simplex virus type 2 (HSV-2). However, the factor(s) involved in this innate protection is not well-defined. Here we report that production of beta interferon (IFN-beta) but not production of IFN-alpha, IFN-gamma, or tumor necrosis factor alpha (TNF-alpha) strongly correlates with innate protection against HSV-2. Local delivery of poly(I:C) and CpG oligodeoxynucleotides induced significant production of IFN-beta in the genital tract and provided complete protection against intravaginal (IVAG) HSV-2 challenge. There was no detectable IFN-beta in mice treated with ligands for TLR4 or TLR2, and these mice were not protected against subsequent IVAG HSV-2 challenge. There was no correlation between levels of TNF-alpha or IFN-gamma in the genital tract and protection against IVAG HSV-2 challenge following TLR ligand delivery. Both TNF-alpha(-/-) and IFN-gamma(-/-) mice were protected against IVAG HSV-2 challenge following local delivery of poly(I:C). To confirm that type I interferon, particularly IFN-beta, mediates innate protection, mice unresponsive to type I interferons (IFN-alpha/betaR(-/-) mice) and mice lacking IFN regulatory factor-3 (IRF-3(-/-) mice) were treated with poly(I:C) and then challenged with IVAG HSV-2. There was no protection against HSV-2 infection following poly(I:C) treatment of IFN-alpha/betaR(-/-) or IRF-3(-/-) mice. Local delivery of murine recombinant IFN-beta protected C57BL/6 and IRF-3(-/-) mice against IVAG HSV-2 challenge. Results from these in vivo studies clearly suggest a strong correlation between IFN-beta production and innate antiviral immunity against HSV-2.     

The in vitro immunomodulatory activity of a synthetic brassinosteroid analogue would account for the improvement of herpetic stromal keratitis in mice

Herpes simplex virus type 1 (HSV-1) induces an ocular chronic immunoinflammatory syndrome named herpetic stromal keratitis that can lead to vision impairment and blindness. We have reported that the synthetic brassinosteroid (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one, designated as 2, is a potent antiviral in vitro and reduces the incidence of murine herpetic stromal keratitis, although it does not exert an antiviral effect in vivo. In the present report, we investigated whether brassinosteroid 2 may play a role in the modulation of the response of epithelial and immune cells to HSV-1 infection. Compound 2 blocked HSV-1-induced activation of NF-kappaB by inhibiting its translocation to the nucleus of infected corneal and conjunctival cells in vitro, as well as significantly reduced the secretion of TNF-alpha in infected NHC cells. Conversely, IL-6 production was enhanced by compound 2 after HSV-1 infection in both cell types. The production of these cytokines was considerably reduced in a LPS-stimulated macrophage cell line after treatment with compound 2. In conclusion, brassinosteroid 2 would be playing a modulating effect as an inductor or inhibitor, depending on the cell type involved. The improvement of disease observed in mice could be a balance between both, the immunostimulating and immunosuppressive effects of brassinosteroid 2 in vivo.